Skip to main content
High RiskFDAfda-F-1532-2023OTHER

Pasteurized Prepared Cheese Product, Queso Blanco, Half the Fat of Cheddar Cheese packaged under the following brands and sizes: 1. Cla...

Category
Units Affected
7,218,700
Recall Date
August 11, 2023
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1532-2023.

Refrigerated pasteurized process cheese products may not be refrigerated at customer level due to labeled refrigeration requirements varying on finished product labels.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1532-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Great Lakes Cheese, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1532-2023.

Great Lakes Cheese, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Great Lakes Cheese, Inc. Recall FAQ

Great Lakes Cheese, Inc. is the subject of a dairy safety report: Pasteurized Prepared Cheese Product, Queso Blanco, Half the Fat of Cheddar Cheese packaged under the following brands and sizes: 1. Cla.... The notice was published on August 11, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 7,218,700 units are potentially affected.